Catalyst Wire Dossier Catalyst Wire Dossier

DEPAKOTE ER

DIVALPROEX SODIUM · AbbVie Inc.
Drug timelines are a Plus or Pro feature.

53 regulatory and trial events tracked for DEPAKOTE ER, covering 2006-08-04 to 2026-03-31. Get the full timeline:

Most recent: FDA Approved: DEPAKOTE ER — Supplemental Application (AbbVie Inc.)

See pricing